Is a complete CGTX research report available?

No complete published report is available for Cognition Therapeutics, Inc. (CGTX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Cognition Therapeutics, Inc. (CGTX)

NASDAQ: CGTX · USD

$0.74

-0.02 (-3.2%)· Recorded snapshot

Market cap	69.9M
Net income (ttm)	-16.8M
EPS (ttm)	-$0.19
Shares out	95.1M
Volume	337,269
Beta	1.80

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -16.8M
EPS (ttm): -$0.19
Market cap: 69.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantenere

Metric	Value
Amount currency	USD
CIK code	0001455365
Company name	Cognition Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	19243B102
Earnings date	2026-11-09
Earnings time	bmo
Employees	14
Employees change	-14
Employees growth	-50%
Enterprise value	$36.5M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2007
Industry	Biotechnology
IPO date	2021-10-08
Is primary listing	Yes
Is SPAC	No
ISIN number	US19243B1026
Last 10-K release date	2026-03-26
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$69.9M
Market cap category	Micro-Cap
Next earnings date	2026-11-09
Options	No
Price	$0.74
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	CGTX
U.S. state	New York
Website	https://www.cogrx.com

Metric

Value

Amount currency

USD

CIK code

0001455365

Company name

Cognition Therapeutics, Inc.

Country

United States

Country code

CUSIP number

19243B102

Earnings date

2026-11-09

Earnings time

bmo

Employees

Employees change

-14

Employees growth

-50%

Enterprise value

$36.5M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2007

Industry

Biotechnology

IPO date

2021-10-08

Is primary listing

Yes

Is SPAC

ISIN number

US19243B1026

Last 10-K release date

2026-03-26

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$69.9M

Market cap category

Micro-Cap

Next earnings date

2026-11-09

Options

Price

$0.74

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

CGTX

U.S. state

New York

Website

https://www.cogrx.com

Metric	Value
Earnings yield	-26.34%
FCF / EV yield	-45.92%
FCF yield	-24.6%
P/B ratio	2.18x
Price / tangible book value	2.18x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-26.34%

FCF / EV yield

-45.92%

FCF yield

-24.6%

P/B ratio

2.18x

Price / tangible book value

2.18x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Profit per employee	$-1.2M
ROA	-78.18%
ROA (5Y)	-71.37%
ROCE	-109.43%
ROE	-83.76%
ROE (5Y)	-86.63%
ROIC	-111.29%

Metric

Value

Profit per employee

$-1.2M

ROA

-78.18%

ROA (5Y)

-71.37%

ROCE

-109.43%

ROE

-83.76%

ROE (5Y)

-86.63%

ROIC

-111.29%

Metric	Value
EPS growth quarters	7
EPS growth years	1
Net income growth quarters	7
Net income growth years	1
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$-20,000
Depreciation and amortization	$50,000
EBIT	$-36.6M
EBITDA	$-36.6M
EPS	$-0.19
FCF per share	$-0.19
Financing cash flow	$40.9M
Free cash flow	$-17.7M
Free cash flow minus SBC	$-19.2M
Investing cash flow	$-11,000
Net borrowing	$-344,000
Net cash flow	$23.2M
Net income	$-16.8M
Operating cash flow minus SBC	$-19.2M
Operating income	$-36.6M
Stock-based compensation	$1.5M

Metric

Value

Capital expenditures

$-20,000

Depreciation and amortization

$50,000

EBIT

$-36.6M

EBITDA

$-36.6M

EPS

$-0.19

FCF per share

$-0.19

Financing cash flow

$40.9M

Free cash flow

$-17.7M

Free cash flow minus SBC

$-19.2M

Investing cash flow

$-11,000

Net borrowing

$-344,000

Net cash flow

$23.2M

Net income

$-16.8M

Operating cash flow minus SBC

$-19.2M

Operating income

$-36.6M

Stock-based compensation

$1.5M

Metric	Value
Book value per share	$0.35
Debt / equity	0.02
Interest coverage	-2,815.46
Long-term assets	$597,000
Long-term liabilities	$422,000
Net cash (debt)	$33.4M
Net cash / market cap	46.44%
Net cash growth	225.28%
Net debt / equity	-1.01
Piotroski F-Score	1
Property, plant and equipment	$597,000
Shareholders' equity	$33M
Tangible book value	$33M
Tangible book value per share	$0.35
Total assets	$38.9M
Total cash	$34M
Total debt	$589,000
Total liabilities	$5.9M
WACC	14.05%

Metric

Value

Book value per share

$0.35

Debt / equity

0.02

Interest coverage

-2,815.46

Long-term assets

$597,000

Long-term liabilities

$422,000

Net cash (debt)

$33.4M

Net cash / market cap

46.44%

Net cash growth

225.28%

Net debt / equity

-1.01

Piotroski F-Score

Property, plant and equipment

$597,000

Shareholders' equity

$33M

Tangible book value

$33M

Tangible book value per share

$0.35

Total assets

$38.9M

Total cash

$34M

Total debt

$589,000

Total liabilities

$5.9M

WACC

14.05%

Metric	Value
Current assets	$38.3M
Current liabilities	$5.5M
Current ratio	7.03
Net working capital	$-996,000
Quick ratio	6.78
Working capital	$32.8M

Metric

Value

Current assets

$38.3M

Current liabilities

$5.5M

Current ratio

7.03

Net working capital

$-996,000

Quick ratio

6.78

Working capital

$32.8M

Metric	Value
Buyback yield / dilution	-65.45%
Dividend yield	0%
Shareholder yield	-65.45%

Metric

Value

Buyback yield / dilution

-65.45%

Dividend yield

Shareholder yield

-65.45%

Metric	Value
150-day SMA	$1.05
1D price change	-3.17%
1M price change	-21.38%
1M total return	-21.38%
1W price change	0.34%
1W total return	0.34%
1Y price change	-56.17%
1Y return CAGR	-56.2%
1Y total return	-56.17%
20-day SMA	$0.81
200-day SMA	$1.07
3M price change	-22.45%
3M total return	-22.45%
3Y price change	-35.41%
3Y return CAGR	-13.56%
3Y total return	-35.41%
50-day SMA	$0.92
50-day SMA vs 200-day SMA	50under200
52-week high	$1.83
52-week high date	2025-10-31
52-week low	$0.55
52-week low date	2026-03-30
5Y price change	-93.91%
5Y return CAGR	-42.88%
5Y total return	-93.91%
6M price change	-42.48%
6M total return	-42.48%
All-time high	$13.80
All-time high date	2021-10-08
All-time low	$0.22
All-time low date	2025-05-28
Average true range (ATR)	$0.06
Average volume	619K
Beta (1Y)	3.75
Beta (2Y)	2.33
Beta (5Y)	1.8
Change from 52-week high	-59.84%
Change from 52-week low	33.61%
Change from all-time high	-94.66%
Change from all-time low	231.22%
Change from open	-3.85%
Day's gap	0.7%
Dollar volume	$247,893
High price	$0.78
Low price	$0.74
Monthly RSI	40.69
Open price	$0.76
Position in 52-week range	0%
Premarket change	1.36%
Premarket close	$0.76
Premarket price	$0.77
Premarket volume	1K
Previous close	$0.76
Price vs 150-day SMA	-29.61%
Price vs 20-day SMA	-8.64%
Price vs 200-day SMA	-31.44%
Price vs 50-day SMA	-20.25%
Relative volume	0.54
Return from IPO open	-93.77%
Return from IPO price	-93.69%
RSI	36.46
Sharpe ratio	-0.38
Sharpe ratio (3Y)	0.41
Sharpe ratio (5Y)	0.06
Sortino ratio	-0.46
Sortino ratio (3Y)	0.7
Sortino ratio (5Y)	0.14
Volume	337.3K
Weekly RSI	36.12
YTD price change	-45.46%
YTD total return	-45.46%

Metric

Value

150-day SMA

$1.05

1D price change

-3.17%

1M price change

-21.38%

1M total return

-21.38%

1W price change

0.34%

1W total return

0.34%

1Y price change

-56.17%

1Y return CAGR

-56.2%

1Y total return

-56.17%

20-day SMA

$0.81

200-day SMA

$1.07

3M price change

-22.45%

3M total return

-22.45%

3Y price change

-35.41%

3Y return CAGR

-13.56%

3Y total return

-35.41%

50-day SMA

$0.92

50-day SMA vs 200-day SMA

50under200

52-week high

$1.83

52-week high date

2025-10-31

52-week low

$0.55

52-week low date

2026-03-30

5Y price change

-93.91%

5Y return CAGR

-42.88%

5Y total return

-93.91%

6M price change

-42.48%

6M total return

-42.48%

All-time high

$13.80

All-time high date

2021-10-08

All-time low

$0.22

All-time low date

2025-05-28

Average true range (ATR)

$0.06

Average volume

619K

Beta (1Y)

3.75

Beta (2Y)

2.33

Beta (5Y)

1.8

Change from 52-week high

-59.84%

Change from 52-week low

33.61%

Change from all-time high

-94.66%

Change from all-time low

231.22%

Change from open

-3.85%

Day's gap

0.7%

Dollar volume

$247,893

High price

$0.78

Low price

$0.74

Monthly RSI

40.69

Open price

$0.76

Position in 52-week range

Premarket change

1.36%

Premarket close

$0.76

Premarket price

$0.77

Premarket volume

Previous close

$0.76

Price vs 150-day SMA

-29.61%

Price vs 20-day SMA

-8.64%

Price vs 200-day SMA

-31.44%

Price vs 50-day SMA

-20.25%

Relative volume

0.54

Return from IPO open

-93.77%

Return from IPO price

-93.69%

RSI

36.46

Sharpe ratio

-0.38

Sharpe ratio (3Y)

0.41

Sharpe ratio (5Y)

0.06

Sortino ratio

-0.46

Sortino ratio (3Y)

0.7

Sortino ratio (5Y)

0.14

Volume

337.3K

Weekly RSI

36.12

YTD price change

-45.46%

YTD total return

-45.46%

Metric	Value
Float	87.5M
Float percentage	92.02%
Shares change (QoQ)	1.61%
Shares change (YoY)	65.45%
Shares held by insiders	1.67%
Shares held by institutions	17.48%
Shares outstanding	95.1M
Short % of float	8.04%
Short % of shares	7.4%
Short ratio	18.9 days

Metric

Value

Float

87.5M

Float percentage

92.02%

Shares change (QoQ)

1.61%

Shares change (YoY)

65.45%

Shares held by insiders

1.67%

Shares held by institutions

17.48%

Shares outstanding

95.1M

Short % of float

8.04%

Short % of shares

7.4%

Short ratio

18.9 days

Cognition Therapeutics, Inc. (CGTX)

Price

Financial snapshot

Fair-value bridge

Latest news · CGTX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CGTX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CGTX

Frequently asked questions